AIM 이뮤노테크AIM 주가

Get insights into the top gainers and losers of Thursday's pre-market session.

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

♻️ 재탕12 Health Care Stocks Moving In Thursday's Pre-Market Session

Keep an eye on the top gainers and losers in Wednesday's session.

Let's have a look at what is happening on the US markets one hour before the close of the markets on Wednesday. Below you can find the top gainers and losers in today's session.

Most active stocks in Wednesday's session

Stay updated with the latest market activity on Wednesday. Explore the most active stocks in today's session and stay informed about the stocks that are in the spotlight.

♻️ 재탕Wednesday's session: top gainers and losers

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top gainers and losers in today's session.

♻️ 재탕12 Health Care Stocks Moving In Wednesday's Intraday Session

AIM ImmunoTech To Present Pre-Clinical Data On Potential Role Of Its Lead Drug Ampligen For Ebola Virus Treatment

AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company"), an immuno-pharma company focused on the development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, today announced

♻️ 재탕[SCHEDULE 13G] SCHEDULE 13G

♻️ 재탕[424B5] 증자 가격 공시 — 424B5

♻️ 재탕[8-K] 중대 사건 — 8-K